Independent Review of Medicines for Malaria Venture（一）.pdfVIP

INDEPENDENT REVIEW OF MEDICINES FOR MALARIA VENTURE Commissioned jointly by the following donors: The UK Department for International Development, The Wellcome Trust, The World Bank (through their grant to MMV), The Swiss Agency for Development and Co-operation, The Bill and Melinda Gates Foundation and The Netherlands Ministry of Foreign Affairs (DGIS). Alan FAIRLAMB Keith BRAGMAN Hassan MSHINDA Adetokunbo LUCAS – Team Leader May 2005 DFID Health Resource Centre 27 Old Street London EC1V 9HL Tel: +44 (0) 207 251 9555 Fax: +44 (0) 207 251 9552 This independent review of MMV was commissioned jointly by the following group of donors: The UK Department for International Development, The Wellcome Trust, The World Bank (through their grant to MMV), The Swiss Agency for Development and Co-operation, The Bill and Melinda Gates Foundation and The Netherlands Ministry of Foreign Affairs (DGIS). The opportunity for a joint donor review was identified following discussions of the larger Donor Co-ordination Group (see Annex 2), and a realization that several donors were independently considering conducting such a review of MMV. The review was seen as an opportunity to reduce the burden on MMV from multiple individual donor reviews as well as an opportunity to develop a common framework for future Product Development Partnership reviews. The donors worked together to develop the Terms of Reference, select the review team, and provided support throughout the review and the completion of this report. Title: Independent Review of Medicines for Malaria Venture Authors: Alan Fairlamb, Keith Bragman, Hassan Mshinda, Adetokunbo Lucas DFID Health Resource Centre 27 Old Street London EC1V 9HL Tel: +44 (0) 20 7251 9555 Fax: +44 (0) 20 7251 9552 TABLE OF CONTENTS Acknowledgements 1 Abbreviations or Trade Names 2 Executive Summary 3 Key Recommendations 5 1 Terms Of Referenc